U.S. Consumer Finance Stock News

KeyBanc’s downgrade of Mach Natural Resources (MNR) to Sector Weight, tied to integration hurdles around new Central Basin Platform and San Juan Basin assets and reduced capital spending, has pushed investors to reassess the partnership’s near term outlook. See our latest analysis for Mach Natural Resources. At a share price of $11.01, Mach Natural Resources has seen pressure build over the past quarter, with a 90 day share price return of 7.25% and a 1 year total shareholder return decline...

If you are wondering whether W. P. Carey is fairly priced or if there is still value on the table, this article will walk you through what the current share price might be telling you. The stock last closed at US$68.92, with returns of 2.2% over 7 days, 6.1% over 30 days, 6.3% year to date, 31.3% over 1 year, 2.2% over 3 years, and 41.1% over 5 years. Taken together, these figures give you a broad picture of how the market has treated the shares across different time frames. Recent coverage...

Why Restaurant Brands International Is On Investor Radars Today Restaurant Brands International (QSR) has caught investor attention recently, with the stock showing mixed short term moves, including a small 1 day decline alongside a modest gain over the past week. See our latest analysis for Restaurant Brands International. While the 1 day share price return of 0.5% decline might catch the eye, the 90 day share price return of 3.19% and 1 year total shareholder return of 19.33% suggest...

Recent performance snapshot Criteo (CRTO) is back on some investors’ radars after a mixed stretch, with the share price showing small moves over the past week and month, and a modest gain in the past 3 months. That recent pattern sits against a longer history where the stock shows a 45.3% negative total return over the past year and a 27% negative total return over 3 years, partly offset by an 8.5% positive total return over 5 years. See our latest analysis for Criteo. At a share price of...

If you are wondering whether General Motors' current share price still offers value, this article walks through what the numbers suggest and how that might fit with your own expectations. The stock closed at US$80.91, with a 5.0% decline over the last 7 days and a 1.0% decline over 30 days, while the 1 year return stands at 57.7% and the 3 year return at 133.6%. Recent coverage has focused on General Motors as a key player in US autos, including its push in areas such as electric vehicles...

Ultra Clean Holdings, Inc. recently presented at the 28th Annual Needham Growth Conference in New York, outlining its role supplying critical cleaning and contamination control equipment for semiconductor manufacturing and AI chip production. The company’s commentary on operational execution, gross margin strength, and its importance to AI-focused semiconductor infrastructure has sharpened investor focus on how it might participate in any broader industry recovery. We’ll now examine how...

Xcel Energy (XEL) is back in focus as investors look ahead to its upcoming fiscal Q4 2025 earnings report and its expanded five year, US$60b capital investment plan. See our latest analysis for Xcel Energy. At a share price of US$75.36, Xcel Energy has seen a 2.7% 7 day share price return and a 2.21% 30 day share price return, while its 1 year total shareholder return of 17.55% and 5 year total shareholder return of 35.63% point to momentum that has built over time despite a softer 90 day...

Investors may be asking whether Collegium Pharmaceutical at around US$46.90 is offering good value right now, or if most of the upside has already been priced in. The share price has seen mixed recent returns, with a 3.9% decline over the past week and a 3.7% decline over the past month, while still sitting on a 40.2% return over 1 year and 98.6% over 5 years. Recent coverage has focused on how investors are reassessing specialty pharmaceutical names like Collegium Pharmaceutical in light of...

monday.com (MNDY) moved back into focus after Barclays cut its expectations on the stock, pointing to softer revenue guidance for late 2025 that indicated slower growth in a still-volatile tech sector. See our latest analysis for monday.com. At a share price of $132.81, monday.com has seen pressure build over recent months, with a 30-day share price return of 11.54% and a 90-day share price return of 26.86%, while the 1-year total shareholder return of 44.80% contrasts with a 3-year total...

AtaiBeckley Inc. recently outlined its 2026 development plans and reported prior positive Phase 2b and extension data for BPL-003 in treatment-resistant depression, alongside progress on VLS-01 and EMP-01, while also announcing the immediate resignation of board member Cosmo Feilding-Mellen with no stated disagreement. The selection of BPL-003 Phase 2b results for a high-profile “Hot Topics” session at a major neuropsychopharmacology meeting underscores the growing scientific interest around...

Earlier in 2026, American Bitcoin Corp reiterated that it ranks among the top twenty publicly traded Bitcoin treasury holders, disclosing reserves of over 5,098 Bitcoin and unveiling a new Bitcoin Yield Metric alongside its existing Satoshis Per Share measure. This move signals an effort to give investors clearer insight into how its sizable Bitcoin holdings behave over time, using metrics tailored specifically to Bitcoin exposure rather than traditional accounting alone. Next, we’ll examine...

If you are wondering whether Harrow's share price still makes sense after recent moves, you are not alone and the numbers give us plenty to talk about. The stock trades at US$48.49, with a 7 day return of a 5% decline, a 30 day return of 8.3% and a 1 year return of 44.9%, while the 3 year return is very large and the 5 year return is also very large. Recent news flow around Harrow has mainly focused on its position in the pharmaceuticals and biotech space and investor interest in how its...

What recent performance says about DaVita (DVA) DaVita (DVA) has drawn investor attention after a period of weaker share performance, with the stock showing negative returns over the past week, month, and past 3 months, as well as over the past year. At a last close of $105.84, DaVita sits below its one-year total return level, which is down 35.8%. Over the past month and past 3 months, returns of 10.3% and 15.9% declines highlight recent pressure on the share price. See our latest analysis...

Technical trigger and rising expectations around Adeia Adeia (ADEA) recently posted a golden cross, where its 50 day moving average moved above the 200 day level. This occurred alongside upward revisions to current quarter earnings estimates, drawing fresh attention from technically focused and fundamentally oriented investors alike. See our latest analysis for Adeia. That technical setup is arriving alongside strong momentum, with Adeia’s 1 month share price return of 47.12% and 1 year total...

In recent days, Postal Realty Trust has drawn attention as technical models flagged its shares as a momentum candidate, while the company continued to expand its USPS‑leased portfolio with 216 acquisitions in 2025 and maintained 99.8% occupancy alongside a largely fixed‑rate debt structure with no maturities until 2028. This combination of strong trading signals and resilient, government‑backed rental income has brought renewed focus to how Postal Realty’s growth and risk profile fit within...

If you are wondering whether Uniti Group’s share price reflects its true worth, you are not alone. This article focuses on what the current price might be telling you about value. The stock recently closed at US$7.50, with returns of 2.7% over 7 days, 1.8% over 30 days, 9.8% year to date, a 22.7% decline over 1 year and a 51.0% decline over 5 years. Recent news coverage around Uniti Group has highlighted its position as a telecommunications infrastructure owner, with commentary often...

Wayland exit puts HNI’s cost savings plan in focus HNI (HNI) plans to close its Wayland, New York, manufacturing plant in 2027, consolidating production into other North American facilities and targeting annual cost savings of about US$7.5 million to US$8.0 million. The move is tied to the integration of Kimball International, with total cost synergies now anticipated at US$68 million by the end of 2028 and expected pre tax consolidation charges of US$14.9 million across 2026 and 2027. See...

In recent days, Marathon Petroleum drew attention as options traders focused on near-the-money February 2026 calls while the energy sector rallied alongside crude oil’s rise to multi‑month highs amid renewed geopolitical tensions. This mix of unusual options positioning and geopolitically driven crude strength has sharpened interest in how Marathon’s refining-focused business might respond to shifting risk sentiment and short-term pricing expectations. Next, we’ll examine how this...

Why Lumen Technologies is on investors’ radar today Lumen Technologies (LUMN) has been drawing attention after a period of share price moves over the past year, prompting investors to reassess how its current valuation lines up with recent financial results. See our latest analysis for Lumen Technologies. That recent 5.4% 1 day share price return and 25.4% 90 day share price return, alongside a 56.4% 1 year total shareholder return but slightly negative 5 year total shareholder return,...

RPM Capital Partners has recently initiated a new position in StubHub Holdings, acquiring 535,850 shares that now account for 6.36% of its reported U.S. equity assets. This move, alongside StubHub’s latest quarter showing higher gross merchandise sales, revenue growth and improved leverage, highlights growing institutional interest in the company’s operating momentum. We’ll now examine how RPM Capital Partners’ new position and StubHub’s improving operating metrics shape the company’s...

Mercury General Corporation recently completed a dual listing of its common stock on NYSE Texas, effective January 15, 2026, while retaining its primary listing on the New York Stock Exchange under the ticker "MCY." This move aligns Mercury General’s exchange presence with its operational footprint in Texas, where it generates more than 7% of its direct written premiums. We’ll now examine how this new NYSE Texas dual listing, tied to Mercury General’s Texas premium base, could influence its...

In early 2026, Moderna raised its 2025 revenue forecast to about US$1.9 billion, outlined meaningful operating expense cuts, and reiterated a path toward cash breakeven by 2028, while highlighting progress in late‑stage vaccines and oncology programs. This combination of tighter cost control, clearer medium‑term financial targets, and advancing mRNA pipeline has prompted analysts and investors to reassess Moderna’s business outlook more favorably. We’ll now examine how Moderna’s higher 2025...

Arrowhead Pharmaceuticals (ARWR) has just combined a third major approval for REDEMPLO (plozasiran) with fresh obesity trial data and sizeable new financings, giving investors several material updates to digest at once. See our latest analysis for Arrowhead Pharmaceuticals. These approvals and obesity trial updates come after a sharp 79.98% 3 month share price return and a very large 1 year total shareholder return of 248.32%. However, the year to date share price return of a 2.27% decline...

Bitdeer Technologies Group (BTDR) is drawing fresh attention after Bitdeer AI announced the deployment of NVIDIA GB200 NVL72 hardware in Malaysia, along with plans to convert former bitcoin mining sites into GPU focused AI data centers. See our latest analysis for Bitdeer Technologies Group. The recent AI push comes after a volatile stretch for Bitdeer, with a 30.09% 7 day and 52.45% 30 day share price return, but a 36.47% 90 day share price decline and a 29.16% 1 year total shareholder...